Jay Venkatesan - Dec 28, 2023 Form 4 Insider Report for Elicio Therapeutics, Inc. (ELTX)

Role: Director
Signature: /s/ Jay Venkatesan
Stock symbol: ELTX
Transactions as of: Dec 28, 2023
Transactions value $: $0
Form type: 4
Date filed: 12/29/2023, 05:05 PM
Previous filing: Jul 19, 2022
Next filing: Jul 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELTX	Stock Option (right to buy)	Award	$0	+4.1K		$0.00	4.1K	Dec 28, 2023	Common Stock	4.1K	$8.26	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date.

Content

The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date.